[go: up one dir, main page]

NO20042337L - Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser - Google Patents

Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser

Info

Publication number
NO20042337L
NO20042337L NO20042337A NO20042337A NO20042337L NO 20042337 L NO20042337 L NO 20042337L NO 20042337 A NO20042337 A NO 20042337A NO 20042337 A NO20042337 A NO 20042337A NO 20042337 L NO20042337 L NO 20042337L
Authority
NO
Norway
Prior art keywords
pyrazolopyimidinones
deuterated
compounds
well
drugs containing
Prior art date
Application number
NO20042337A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf-Giesbert Alken
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of NO20042337L publication Critical patent/NO20042337L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20042337A 2001-11-07 2004-06-04 Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser NO20042337L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10155018A DE10155018A1 (de) 2001-11-07 2001-11-07 Deuterierte Pyrazolopyrimidinone sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004216 WO2003039439A2 (fr) 2001-11-07 2002-11-07 Pyrazolopyrimidinones deuterees et medicaments contenant ces composes

Publications (1)

Publication Number Publication Date
NO20042337L true NO20042337L (no) 2004-06-04

Family

ID=7705148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042337A NO20042337L (no) 2001-11-07 2004-06-04 Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser

Country Status (16)

Country Link
US (1) US20050069276A1 (fr)
EP (1) EP1444234A2 (fr)
JP (1) JP2005509646A (fr)
KR (1) KR20050044381A (fr)
CN (1) CN1606557A (fr)
CA (1) CA2470271A1 (fr)
CZ (1) CZ2004639A3 (fr)
DE (1) DE10155018A1 (fr)
HU (1) HUP0401721A3 (fr)
IL (1) IL161790A0 (fr)
IS (1) IS7246A (fr)
NO (1) NO20042337L (fr)
NZ (1) NZ533385A (fr)
PL (1) PL369654A1 (fr)
RU (1) RU2004117157A (fr)
WO (1) WO2003039439A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090291958A1 (en) * 2006-06-08 2009-11-26 Auspex Pharmaceuticals, Inc. Substituted PDE5 inhibitors
US20080194529A1 (en) * 2007-02-12 2008-08-14 Auspex Pharmaceuticals, Inc. HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS
ES2395241T3 (es) * 2007-03-07 2013-02-11 Concert Pharmaceuticals Inc. Derivados deuterados de piperazina como compuestos antianginosos
BRPI0916769A2 (pt) 2008-07-15 2017-09-26 Theracos Inc derivados de benzilbenzeno deuterados e métodos de uso
CN102584592B (zh) * 2011-12-28 2014-10-15 李进 一种氘代的拟除虫菊酯化合物及其制备方法和应用
ES2682043T3 (es) 2012-07-30 2018-09-18 Concert Pharmaceuticals Inc. Ibrutinib deuterado
WO2020151605A1 (fr) * 2019-01-25 2020-07-30 青岛吉澳医药科技有限公司 Dérivés de benzylaminopyrimidinedione deutérés et leur utilisation
WO2021236891A1 (fr) * 2020-05-20 2021-11-25 Augusta University Research Institute, Inc. Inhibiteurs de phosphodiestérase ciblant l'intestin
CN116444496B (zh) * 2023-06-16 2023-11-24 药康众拓(北京)医药科技有限公司 一种嘧啶联氘代吡唑类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents

Also Published As

Publication number Publication date
DE10155018A1 (de) 2003-07-10
JP2005509646A (ja) 2005-04-14
WO2003039439A2 (fr) 2003-05-15
IS7246A (is) 2004-04-30
RU2004117157A (ru) 2006-01-10
IL161790A0 (en) 2005-11-20
US20050069276A1 (en) 2005-03-31
HUP0401721A3 (en) 2005-11-28
HUP0401721A2 (hu) 2005-08-29
EP1444234A2 (fr) 2004-08-11
CN1606557A (zh) 2005-04-13
WO2003039439A3 (fr) 2003-10-16
CA2470271A1 (fr) 2003-05-15
CZ2004639A3 (cs) 2004-09-15
PL369654A1 (en) 2005-05-02
KR20050044381A (ko) 2005-05-12
NZ533385A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
AR028414A1 (es) Compuestos quimicos
ATE397928T1 (de) Glukokinase beeinflussende verbindungen
AR028563A1 (es) Compuestos heterociclicos que contienen n
IS6971A (is) Ný efnasambönd
DK1326832T3 (da) Kemiske forbindelser
DE60206889D1 (de) Pharmazeutische formulierung enthaltend bicalutamid
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
ITMI20021532A1 (it) Composti chimici
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20042337L (no) Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
DE60228478D1 (de) Aryl-annellierte azapolyzyklische verbindungen
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
SE0200465D0 (sv) Chemical compounds
SE0103797D0 (sv) Chemical compounds
SE0200327D0 (sv) Chemical compounds
SE0201706D0 (sv) Chemical compounds
SE0202656D0 (sv) Chemical compounds
SE0203821D0 (sv) Chemical Compounds
SE0203827D0 (sv) Chemical Compounds
SE0004925L (sv) Kemiska föreningar
AR028304A1 (es) Compuestos quimicos
SE0003664D0 (sv) Chemical compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application